Cor Vasa 2022, 64(4):381-389 | DOI: 10.33678/cor.2021.142

(Outcomes of pregnancy in pre-existing cardiomyopathy and after heart transplantation)

Lenka Vojtičková^a, Miloš Kubánek^a, Jana Bínová^a, Jiří Gurka^a, Markéta Hegarová^a, Marianna Podzimková^a, Lenka Hošková^a, Alice Krebsová^a, Ivan Málek^a, Vojtěch Melenovský^a, Ivan Netuka^b, Josef Cindr^{b, c, d}, Josef Kautzner^a, Antonín Pařízek^c

^a Klinika kardiologie, Institut klinické a experimentální medicíny, Praha

^b Klinika kardiovaskulární chirurgie, Institut klinické a experimentální medicíny, Praha

^c Gynekologicko-porodnická klinika, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze

^d Gynekologická ambulance, Institut klinické a experimentální medicíny, Praha

Introduction: Pregnancy in females with pre-existing cardiomyopathy with left-ventricular systolic dysfunction and/or after heart transplantation is associated with risks for both the mother and the child. Thus, it is not recommended in the majority of patients. However, in selected cases, with awareness of the risks, pregnancy may be considered. We aimed to analyse a group of patients with heart failure and/or after heart transplantation (HTx) who were pregnant and gave birth to a living new-born during follow-up in our institution.

Keywords: Dilated cardiomyopathy, Heart transplantation, Pregnancy

Received: December 13, 2021; Revised: December 13, 2021; Accepted: December 26, 2021; Published: September 1, 2022  Show citation